Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Langley

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Clinical Therapeutics|July 1, 1994
A cost-benefit analysis of four hormonal contraceptive methodsB G Ortmeier, K A Sauer, P C Langley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Commentary on Langley and McKenney PapersT Ashraf, P C Langley, J W Hay, et al.
Pharmacoeconomics|November 3, 1996
A utility assessment of oral and intravenous ganciclovir for the maintenance treatment of AIDS-related cytomegalovirus retinitisE S Johnson, S D Sullivan, E Mozaffari, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
From research into practice: how should healthcare organizations/governments decide about lipid therapy and who will pay? Reactor panel and open forumP C Langley, J W Hay, J S Schwartz, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: II. Cost-effectivenessA Davies, P C Langley, N A Keks, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Clinical Therapeutics|July 1, 1994
A cost-benefit analysis of four hormonal contraceptive methodsB G Ortmeier, K A Sauer, P C Langley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Commentary on Langley and McKenney PapersT Ashraf, P C Langley, J W Hay, et al.
Pharmacoeconomics|November 3, 1996
A utility assessment of oral and intravenous ganciclovir for the maintenance treatment of AIDS-related cytomegalovirus retinitisE S Johnson, S D Sullivan, E Mozaffari, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
From research into practice: how should healthcare organizations/governments decide about lipid therapy and who will pay? Reactor panel and open forumP C Langley, J W Hay, J S Schwartz, et al.
Clinical Therapeutics|April 2, 1998
Risperidone versus haloperidol: II. Cost-effectivenessA Davies, P C Langley, N A Keks, et al.
Pageof 4